Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider

• Main Authors: Brittany A. Klein (Author), Muhammad Ali Shazib (Author), Alessandro Villa (Author), Fábio de Abreu Alves (Author), Piamkamon Vacharotayangul (Author), Stephen Sonis (Author), Stefano Fedele (Author), Nathaniel S. Treister (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immune checkpoint inhibitors (ICIs) are a revolutionary class of antineoplastic therapy that restore anti-tumor immunity. Consequences of this enhanced immune response include a multitude of immune related adverse events (irAEs) that can affect any body system, including the mouth. Orofacial irAEs r...